Alternatives to PAIN Act

HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act. Issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- The Acupuncture for our Seniors Act (H.R. 3133) - Alternatives to Prevent Addiction in the Nation Act (H.R. 7142/S. 3832)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of the Honoring Our PACT Act (Public Law No: 117-168) Implementation of the Deborah Sampson Act (included within Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020 Public Law No: 116-315), and women veterans policy Afghan Allies Protection Act (H.R. 3808/S. 1786) Support of Additional Special Immigrant Visas included within Fiscal Year 2024 State, Foreign Operations, and Related Programs Appropriations Act Equal Access to Contraception for Veterans Act (H.R. 894) Access to Contraception for Servicemembers and Dependents Act (S. 1527) Elizabeth Dole Home Care Act (H.R. 542/S. 141) Servicemembers and Veterans Empowerment and Support Act of 2023 (H.R. 2441/S. 1028) The GI Bill Restoration Act (S. 3257/H.R. 1255) Opposition to the 90/10 roll back provision included within College Cost Reduction Act (H.R. 6951) Marijuana Safe Harbor Act (H.R. 2682) Voting Overseas Treated Equally for Servicemembers (VOTES) Act (H.R. 6242) Guard and Reserve GI Bill Parity Act (H.R. 1836) Women Involuntary Separated Earnings Remittance Act (WISER Act) (H.R. 9725) Loved Ones Internment Act (H.R. 9804) Burn Pit Elimination Act (H.R. 9171/S. 4627) Servicemember Quality of Life Improvement and National Defense Authorization Act for FY25 (H.R. 8070) National Defense Authorization Act for FY25 (S. 4638) Retroactive language in Sec. 549L(b) of S. 4638 of the FY25 NDAA addressing issues with Marine Corps Excess Leave Program Law Improving Access to Prenatal Care for Military Families Act (S. 5330) Alternatives to PAIN Act (H.R. 7142/S. 3832)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office

H.R.7142/S.3838 Alternatives to PAIN Act IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Access to innovative non-opioid medicines; Alternatives to PAIN, HR 7142; Alternatives to PAIN, S 3832.

Client expense: Not reported · Firm income: Not reported

Access to innovative non-opioid medicines; Alternatives to PAIN, HR 7142; Alternatives to PAIN, S 3832.

Client expense: Not reported · Firm income: Not reported

H.R. 7142/S. 3832, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to cell and gene therapy. HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- The Acupuncture for our Seniors Act (H.R. 3133) - Alternatives to Prevent Addiction in the Nation Act (H.R. 7142/S. 3832)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.7142/S.3838 Alternatives to PAIN Act IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R. 7142/S. 3832, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- The Acupuncture for our Seniors Act (H.R. 3133) - Alternatives to Prevent Addiction in the Nation Act (H.R. 7142/S. 3832)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; General education about kidney disease, including APOL-1; H.R. 7085 - the BIOSECURE Act; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; H.R. 7142/S. 3832 - The Alternatives to PAIN Act.

Client expense: $980,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- The Acupuncture for our Seniors Act (H.R. 3133) - Alternatives to Prevent Addiction in the Nation Act (H.R. 7142/S. 3832)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act (H.R. 7142/S. 3832) to prevent unnecessary exposure to opioids and ensure access to the wide array of FDA-approved, safe, and effective non-opioid pain management approaches for Americas seniors.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Implementation of P.L. 117-169 provisions related to Medicare prescription drugs; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; H.R. 7142/S. 3832 - The Alternatives to PAIN Act.

Client expense: $1,150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE